LLY Stock: Should You Buy After A 20% Rise?
We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...
STAT4d
Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Is Eli Lilly Stock a Buy?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
AOL13d
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
NBC Washington24d
Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall
Eli Lilly's GLP-1 drugs Mounjaro and Zepbound ... Lilly Institute for Genetic Medicine in Boston, away from Lilly's headquarters in Indianapolis and in one of the U.S. epicenters for this work.